Biomedical Science Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
Conditions:   Melanoma;   Non-small Cell Lung Cancer;   Head and Neck Squamous Cell Carcinoma Interventions:   Biological: AMT-116 CAR-T cells;   Biological: AMT-253 CAR-T cells Sponsor:   Beijing Immunochina Medical Science& Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials